EnglishУкраїнська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Kuzminova N.V., Romanova V.О., Serkova V.K., Belovol О.М., Knyazkova І.І., Gavriluk А.О.

    NEW POSSIBILITIES OF CORRECTION OF CLINICAL STATUS AND ENDOTHELIAL DYSFUNCTION IN CORONARY HEART DISEASE PATIENTS


    About the author: Kuzminova N.V., Romanova V.О., Serkova V.K., Belovol О.М., Knyazkova І.І., Gavriluk А.О.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation 112 patients with coronary heart disease (CHD) were examined: 76 of them were diagnosed with stable CHD, 36 patients were hospitalized with acute coronary syndrome. To assess the effectiveness of treatment, patients were divided into two groups. The first group (n=69) received complex basic therapy of coronary heart disease. Patients of the second group (n=43) additionally to basic therapy received a fixed combination of meldonium (180 mg) with gamma-butyrobetaine (60 mg) orally 2 capsules twice daily during 4 weeks. Complex therapy of CHD patients with the combination of meldonium and gamma-butyrobetaine (was evaluated 1 month after start) contributed to a significant (p<0,05) improvement of both patients clinical condition (quality of life, reduction of angina attacks frequency, increased of treatment satisfaction) and functional status of endothelium (its vasomotor and adhesive functions) compared to traditional therapy.
    Tags coronary heart disease, endothelial dysfunction, meldonium, gamma-butyrobetaine
    Bibliography
    • Voronkov LG. Korrektsiya disfunktsii endoteliya kak klyuchevoye zveno v kardiovaskulyarnoy i tserebrovaskulyarnoy farmakoterapii: aktualnost novykh podkhodov. Kardiologiya: ot nauki k praktike. 2017; 27(3):33-47. [in Russian]
    • Zupanets ÍA, Shebeko SK, Otrishko IA. Znacheniye elementov sinergicheskoy politropnosti v mekhanizme realizatsii terapevticheskogo potentsiala preparata Kapikor. Therapia. 2015; [in Russian]
    • Katerenchuk IP. Farmakoterapevtychni mozhlyvosti odnochasnoyi korektsiyi metabolizmu miokarda i endotelialnoyi dysfunktsiyi v patsiyentiv z ishemichnoyu khvoroboyu sertsya, poyednanoyu z arterialnoyu hipertenziyeyu. Kardiologiya: ot nauki k praktike. 2015;15(2):27-36. [in Ukrainian]
    • Kovalenko VM, Kornatskyi VM, redaktory. Stres i khvoroby systemy krovoobihu. Kyiv: Derzh. ustanova «Nats. nauk. tsentr «Instytut kardiolohiyi im. akad. M.D. Strazheska»; 2015. 365 s. [in Ukrainian]
    • Korzh AN, Krasnokutskiy SV, Vaskiv NN. Vozmozhnosti medikamentoznoy korrektsii disfunktsii endoteliya u bolnykh khronicheskoy ishemicheskoy boleznyu serdtsa. Sertse í sudyny. 2015; 2:50-5. [in Russian]
    • Prikhodko VYu, Kashkovskiy DO, Kononenko YeA, Prikhodko VM. Novyye vozmozhnosti v patogeneticheskoy terapii patsiyentov s khronicheskoy ishemicheskoy boleznyu golovnogo mozga i serdtsa. Semeynaya meditsina. 2015; 62(6):47-50. [in Russian]
    • Snyehiryov P. Vsesvitniy den sertsya yak haslo ta zmist zasidannya Prezydiyi NAMN Ukrayiny [Elektronnyy resurs]. 2016; 1060(39). Dostupno: http://www.apteka.ua/article/387041. [in Ukrainian]
    • Solomenchuk TM, Slaba NA, Chynhryan HV, Protsko VV, Bedzay AO. Optymizatsiya likuvannya khvorykh na prohresuyuchu stenokardiyu: mozhlyvosti metabolichnoyi terapiyi. Kardiologiya: ot nauki k praktike. 2016;22(3):89-104. [in Ukrainian]
    • Syakste NI, Dzintare MYa, Kalvinsh IYa. Rol induktsii NO v mekhanizme deystviya tsitoprotektora Kapikora – originalnogo regulyatora endotelialnoy funktsii. Medychní perspektyvy. 2012;17(2):1-7. [in Ukrainian]
    • Camici GG, Savarese G, Akhmedov A, Lüscher TF. Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease. Eur. Heart J. 2015; 36(48):3392–3403.
    • Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al.  Non-invasive detection of endothelial disfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov7; 340(8828):1111-5. PMID: 1359209 DOI: 10.1016/0140-6736(92)93147-f
    • 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013; 34:2949-3003. https://doi.org/10.1093/eurheartj/eht296
    • Kuzminova NV, Osovska NY, Lozinsky SE, Knyazkova II.  Characteristics of changes and clinical and instrumental predictors of the severity of structural remodelling of carotid arteries in hypertensive patients. Arterial Hypertension. 2016; 20(2):60-67. DOI: 10.5603/AH.2016.0010 ISSN 2449-6170.
    • Serkova VK, Pavlov SV, Romanova VA, Monastyrskiy YuI, Ziepko SM, Kuzminova NV. Medical expert system for assessment of coronary heart disease destabilization, based on the analysis of the level of soluble vascular adhesion molecules. Proceedings of SPIE – the international society for optical engineering. Photonics Applications in Astronomy, Communications, Industry, and High Energy Physics Experiments. 2017; 10445:104453O-104453O-8.
    • Sjakste N, Kalvinsh I. Mildronate: an antiischemic drug with multiple indications. Pharmacologyonline. 2006; 1:1-18.
    Publication of the article «World of Medicine and Biology» №3(69), 2019 year, 089-094 pages, index UDK 616-005.4-08
    DOI 10.26724/2079-8334-2019-3-69-89-94